Consolidative autologous hematopoietic cell transplant plus Rituxan versus Rituxan alone didn't present a major distinction in survival amongst sure sufferers with mantle cell...
Newly identified sufferers with a number of myeloma could have greater MRD-negativity charges when handled with Tecvayli alone or with Revlimid. Sufferers with...